72 Fla. L. Rev. F. 1 (2020)
View the article via pdf

Categories

Antitrust & Trade LawFlorida Law Review Forum

Abstract

This Essay suggests a framework for how to conceptualize “killer acquisitions” in the biotech sector. In a killer acquisition, a larger branded pharmaceutical company buys a start-up company with a pipeline product with the intention to shut the pipeline product down. The Essay offers a way to police against acquisitions that may hurt consumers and still encourage pro-competitive acquisitions that may improve innovation and consumer welfare. Read More.